Seelos TherapeuticsSEELQ
13F holders, Q4 2024 (December 31)2holders −13
0new positions
13sold out
$0.23avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Seelos Therapeutics Inc. (SEELQ) in their 13F filings, down 13 from Q3 2024. 0 opened new positions and 13 sold out. The largest holders were AdvisorShares Investments LLC ($5K) and Vermillion & White Wealth Management Group, LLC ($2).
- Company
- Seelos Therapeutics Inc.
- CUSIP
- 81577F406
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 13 | $77K |
All 13F filers, Q3 2024 → Q4 2024: 2,430 shares bought and 20,493 shares sold, net −18,063 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| AdvisorShares Investments LLC | 0.00% | Add +13.4% | 20,543 | $5K |
| Vermillion & White Wealth Management Group, LLC | 0.00% | No change | 7 | $2 |
"% of holder's portfolio" is SEELQ's weight in each manager's 13F, not the share of Seelos Therapeutics Inc. the manager owns.